Hispanic Broadcasting
Hispanic Broadcasting Newswire

Hispanic Broadcasting Newswire

Comprehensive Real-Time News Feed for Hispanic Broadcasting.

Results 1 - 20 of 79 in Hispanic Broadcasting

  1. Carolyn Purwin Ryan, Attorney, Cipriani & Werner, P.C. to Speak at The Knowledge Group's WebcastRead the original story

    Wednesday Feb 3 | PR Log

    Carolyn Purwin Ryan, Attorney, Cipriani & Werner, P.C. to Speak at The Knowledge Group's The FDA's Hospira Symbiq Infusion System Alert: Patient Care and Medical Cybersecurity Implications Uncovered LIVE Webcast NEW YORK - Feb. 3, 2016 - PRLog -- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Carolyn Purwin Ryan, Attorney, Cipriani & Werner, P.C. will speak at the Knowledge Group's webcast entitled: "The FDA's Hospira Symbiq Infusion System Alert: Patient Care and Medical Cybersecurity Implications Uncovered LIVE Webcast." This event is scheduled for May 11, 2016 @ 10:00 AM to 12:00 PM ET.

    Comment?

  2. Carol S. Doty, Partner, Kaufman Borgeest & Ryan LLP to Speak at The Knowledge Group's WebcastRead the original story

    Wednesday Feb 3 | PR Log

    Carol S. Doty, Partner, Kaufman Borgeest & Ryan LLP to Speak at The Knowledge Group's The FDA's Hospira Symbiq Infusion System Alert: Patient Care and Medical Cybersecurity Implications Uncovered LIVE Webcast NEW YORK - Feb. 3, 2016 - PRLog -- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Carol S. Doty, Partner, Kaufman Borgeest & Ryan LLP will speak at the Knowledge Group's webcast entitled: "The FDA's Hospira Symbiq Infusion System Alert: Patient Care and Medical Cybersecurity Implications Uncovered LIVE Webcast." This event is scheduled for May 11, 2016 @ 10:00 AM to 12:00 PM ET.

    Comment?

  3. Pfizer Reports Fourth-Quarter And Full-Year 2015 ResultsRead the original story

    Monday Feb 1 | BioSpace

    Pfizer Inc. reported financial results for fourth-quarter and full-year 2015 and provided 2016 financial guidance. "Forward-Looking Information and Factors That May Affect Future Results" On September 3, 2015, Pfizer acquired Hospira, Inc. .

    Comment?

  4. Pfizer forecasts 2016 revenue, earnings below estimatesRead the original story w/Photo

    Tuesday Feb 2 | Channelnewsasia.com

    U.S. drugmaker Pfizer Inc , which is in the process of buying Botox-maker Allergan Plc for US$160 billion, forecast 2016 revenue and earnings below analysts' estimates, citing generic competition and a strong dollar. The Pfizer logo is pictured on the company's World Headquarters building in the Manhattan borough of New York November 23, 2015.

    Comment?

  5. HospiraRead the original story

    Jan 5, 2016 | US Food and Drug Administration

    Hospira, Inc., a Pfizer company, has announced a voluntary recall of one lot of, MAGNESIUM SULFATE IN WATER FOR INJECTION 40 mg/mL 2g total, 50 mL to the user level due to a confirmed customer report of an incorrect barcode on the primary bag labeling. The product has a barcode identifying the product contents on both the overwrap and on the primary container.

    Comment?

  6. Admetsys Collaborates with Hospira to Prevent Hypoglycemia in Patients at Diabetic RiskRead the original story w/Photo

    Tuesday Jan 26 | PRWeb

    Admetsys is excited to collaborate with Hospira in putting patient safety first, actively defending against hypoglycemia in patients at diabetic risk. Admetsys, the biomedical technology company that has developed the world's first automated blood glucose control system for hospital and surgical care, today announced that it has entered into an agreement with Hospira for supply of private label 50% Dextrose for Injection in Hospira's Ansyra II polypropylene syringe system.

    Comment?

  7. Cubist Pharms., Inc. v. Hospira, Inc.Read the original story w/Photo

    Monday Jan 25 | JD Supra

    Case Name: Cubist Pharms., Inc. v. Hospira, Inc. , 2015-1197, 2015-1204, 2015-1259, 2015 U.S. App.

    Comment?

  8. $5M donation from the Hospira Foundation will support research in cancer careRead the original story w/Photo

    Sunday Jan 17 | EurekAlert!

    The Hospira Foundation has donated $5 million to the University of Chicago Medicine to create the Hospira Foundation Professorship in Oncology. This position significantly bolsters the University's capacity to conduct pioneering research in cancer.

    Comment?

  9. $5M Donation From the Hospira Foundation Will Support Research in...Read the original story

    Monday Jan 18 | Newswise

    The Hospira Foundation has donated $5 million to the University of Chicago Medicine to create the Hospira Foundation Professorship in Oncology. This position significantly bolsters the University's capacity to conduct pioneering research in cancer.

    Comment?

  10. Court Report - January 2016 #3Read the original story w/Photo

    Monday Jan 18 | JD Supra

    Merck Sharp & Dohme B.V. v. Teva Pharmaceuticals USA Inc. 1:15-cv-00806; filed September 11, 2015 in the District Court of Delaware Infringement of U.S. Patent No.

    Comment?

  11. Pfizer Said to Weigh Sale of Pump Unit Acquired in Hospira DealRead the original story

    Wednesday Jan 13 | The Washington Post

    Pfizer Inc. is weighing a sale of the pumps and devices business it acquired in last year's purchase of Hospira Inc., people with knowledge of the matter said. The U.S. drugmaker could fetch about $2 billion from a potential sale, the people said, asking not to be identified as the details are private.

    Comment?

  12. Pfizer Mulls Over Selling Hospira's Pump Unit for ~$2 BillionRead the original story

    Wednesday Jan 13 | BioSpace

    Pfizer Inc. is weighing a sale of the pumps and devices business it acquired in last year's purchase of Hospira Inc., people with knowledge of the matter said. The U.S. drugmaker could fetch about $2 billion from a potential sale, the people said, asking not to be identified as the details are private.

    Comment?

  13. Hospira's Magnesium Lot 53-113-JT May Have Barcode for HeparinRead the original story

    Jan 7, 2016 | ASHP

    For the second time in a year, Hospira Inc. is recalling bags of magnesium sulfate because their barcode may in fact be the machine-readable code for 1000-mL bags of heparin sodium 2 units/mL. The company on January 5 announced the recall of 40-mg/mL magnesium sulfate in water for injection lot 53-113-JT.

    Comment?

  14. Hospira Issues a Voluntary Nationwide Recall of One Lot of Magnesium...Read the original story

    Jan 5, 2016 | US Food and Drug Administration

    FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

    Comment?

  15. Propriety of a Certificate of Correction Requires Assessment of the...Read the original story w/Photo

    Dec 31, 2015 | JD Supra

    Propriety of a Certificate of Correction Requires Assessment of the Teachings of the Specification as a Whole - Cubist Pharms., Inc. v. Hospira, Inc. In affirming that a certificate of correction may properly be used to correct a later-discovered error in a chemical diagram, the U.S. Court of Appeals for the Federal Circuit looked to the teachings of the specification as a whole to determine that the certificate merely conformed the erroneous diagram to the rest of the specification and did not change the scope of the claims.

    Comment?

  16. Cubist Pharmaceuticals, Inc. v. Hospira Inc.Read the original story w/Photo

    Dec 30, 2015 | jdsupra.com

    Mistakes happen; there is even a book, entitled Human Error , that discusses how and why they happen. The Federal Circuit addressed the consequences of human error in a surprisingly lenient fashion in Cubist Pharmaceuticals, Inc. v.

    Comment?

  17. Hargreaves Services plc (HSP) PT Lowered to GBX 270Read the original story w/Photo

    Dec 20, 2015 | AmericanBankingNews.com

    The brokerage currently has a "hold" rating on the stock. Jefferies Group's price objective indicates a potential upside of 1.90% from the company's previous close.

    Comment?

  18. Merger & Acquisition ETFs: Will 2016 Replicate 2015?Read the original story w/Photo

    Dec 16, 2015 | Seeking Alpha

    Merger and acquisition activities across a number of sectors are going through the roof this year. Low interest rates, which may now last only a few days, led the companies to make the most of the easy money era in the U.S. Low interest rates make borrowing cheaper, and in turn, put less stress on companies' balance sheets post acquisition.

    Comment?

  19. Hargreaves Services plc (HSP) Price Target Lowered to GBX 270 at Jefferies GroupRead the original story w/Photo

    Dec 15, 2015 | AmericanBankingNews.com

    The firm currently has a "hold" rating on the stock. Jefferies Group's price target points to a potential upside of 1.94% from the stock's current price.

    Comment?

  20. Michael Price Sells Holding in HospiraRead the original story w/Photo

    Dec 4, 2015 | GuruFocus.com

    Michael Price is known to prefer out-of-favor small cap companies that offer good value when he makes his investment decisions, and many of his third-quarter transactions fit that description, but some of his largest transactions involved companies with caps that exceeded several billion dollars. A good example is Price's most significant third-quarter transaction the sale of his 400,000-share stake in Hospira Inc. , a Lake Forest, Illinois-based pharmaceutical and medical device company, for an average price of $89.48 per share.

    Comment?